"[Glaxo-Smith-Kline] is making its trial database available to researchers in an attempt to steer the use toward scientific purposes. It is not merely providing summary data, but is sharing patient-level data, which will support a broader array of research and is a higher level of transparency...this step alone is remarkable...I think we will look back on today as a watershed moment." Hope this pans out. - Ruchira S. Datta